Longeveron stock jumps on Alzheimer’s trial results
October 05, 2023 at 08:13 AM EDT
Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||